UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002

Preventive veterinary medicine, 2005-06, Vol.69 (1), p.109-127

2005

Volltextzugriff (PDF)

Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma

Journal of immunotherapy (1997), 2013-07, Vol.36 (6), p.350

2013

Volltextzugriff (PDF)

Lack of evidence for a role of islet autoimmunity in the aetiology of canine diabetes mellitus

PloS one, 2014, Vol.9 (8), p.e105473-e105473

2014

Volltextzugriff (PDF)

Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity -evaluation of a new, fully automated non-radiometric assay

International journal of oncology, 2009-02, Vol.34 (2), p.505-510

2009

Volltextzugriff (PDF)

Serum thymidine kinase activity in clinically healthy and diseased cats: a potential biomarker for lymphoma

Journal of feline medicine and surgery, 2013-02, Vol.15 (2), p.142-147

2013

Volltextzugriff (PDF)

Mammary Tumor Development in Dogs Is Associated with BRCA1 and BRCA2

Cancer research (Chicago, Ill.), 2009-11, Vol.69 (22), p.8770-8774

2009

Volltextzugriff (PDF)

A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs

Research in veterinary science, 2006-02, Vol.80 (1), p.17-24

2006

Volltextzugriff (PDF)

Efficient mapping of mendelian traits in dogs through genome-wide association

Nature genetics, 2007-11, Vol.39 (11), p.1321-1328

2007

Volltextzugriff (PDF)

Duplication of FGF3 , FGF4 , FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs

Nature genetics, 2007-11, Vol.39 (11), p.1318-1320

2007

Volltextzugriff (PDF)

Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival

Canadian journal of veterinary research, 2007-10, Vol.71 (4), p.292-299

2007

Volltextzugriff (PDF)

Homogeneous assay for real-time and simultaneous detection of thymidine kinase 1 and deoxycytidine kinase activities

Analytical biochemistry, 2013-01, Vol.432 (2), p.155-164

2013

Volltextzugriff (PDF)

The ESR1 gene is associated with risk for canine mammary tumours

BMC veterinary research, 2013-04, Vol.9 (1), p.69-69

2013

Volltextzugriff (PDF)

Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma

Journal of immunotherapy, 2008-05, Vol.31 (4), p.377-384

2008

Volltextzugriff (PDF)

Serum Thymidine Kinase Activity in Dogs with Malignant Lymphoma: A Potent Marker for Prognosis and Monitoring the Disease

Journal of veterinary internal medicine, 2004-09, Vol.18 (5), p.696

2004

Volltextzugriff (PDF)

Electrochemical treatment of tumours

von Euler, Henrik

2002

Volltextzugriff (PDF)

A dog pedigree with familial medullary thyroid cancer

International journal of oncology, 2006-11, Vol.29 (5), p.1173-1182

2006

Volltextzugriff (PDF)

Lack of Evidence for a Role of Islet Autoimmunity in the Aetiology of Canine Diabetes Mellitus: e105473

PloS one, 2014-08, Vol.9 (8)

2014

Volltextzugriff (PDF)

Electrochemical treatment of tumours

Bioelectrochemistry, 2000-02, Vol.51 (1), p.1-11

2000

Volltextzugriff (PDF)

Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures

International journal of molecular medicine, 2005-12, Vol.16 (6), p.979

2005

Volltextzugriff (PDF)

Animal models for treatment of unresectable liver tumours: a histopathologic and ultra-structural study of cellular toxic changes after electrochemical treatment in rat and dog liver

Bioelectrochemistry (Amsterdam, Netherlands), 2003-04, Vol.59 (1), p.89-98

2003

Volltextzugriff (PDF)

Serum Thymidine Kinase Activity in Dogs with Malignant Lymphoma: A Potent Marker for Prognosis and Monitoring the Disease

Journal of veterinary internal medicine, 2004-09, Vol.18 (5), p.696-702

2004

Volltextzugriff (PDF)

Cellular toxicity induced by different pH levels on the R3230AC rat mammary tumour cell line. An in vitro model for investigation of the tumour destructive properties of electrochemical treatment of tumours

Bioelectrochemistry (Amsterdam, Netherlands), 2002-12, Vol.58 (2), p.163-170

2002

Volltextzugriff (PDF)

Efficient mapping of mendelian traits in dogs through genome-wide association

Nature genetics, 2007, Vol.39 (11), p.1322-1328

2007

Volltextzugriff (PDF)

Electrochemical treatment (EChT) effects in rat mammary and liver tissue. In vivo optimizing of a dose-planning model for EChT of tumours

Bioelectrochemistry (Amsterdam, Netherlands), 2001-11, Vol.54 (2), p.117-124

2001

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002

Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma

Lack of evidence for a role of islet autoimmunity in the aetiology of canine diabetes mellitus

Monitoring therapy in canine malignant lymphoma and leukemia with serum thymidine kinase 1 activity -evaluation of a new, fully automated non-radiometric assay

Serum thymidine kinase activity in clinically healthy and diseased cats: a potential biomarker for lymphoma

Mammary Tumor Development in Dogs Is Associated with BRCA1 and BRCA2

Genome-wide analyses implicate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/B

A non-radiometric method for measuring serum thymidine kinase activity in malignant lymphoma in dogs

Efficient mapping of mendelian traits in dogs through genome-wide association

Duplication of FGF3 , FGF4 , FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs

Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival

Homogeneous assay for real-time and simultaneous detection of thymidine kinase 1 and deoxycytidine kinase activities

The ESR1 gene is associated with risk for canine mammary tumours

Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma

Serum Thymidine Kinase Activity in Dogs with Malignant Lymphoma: A Potent Marker for Prognosis and Monitoring the Disease

Electrochemical treatment of tumours

A dog pedigree with familial medullary thyroid cancer

Lack of Evidence for a Role of Islet Autoimmunity in the Aetiology of Canine Diabetes Mellitus: e105473

Electrochemical treatment of tumours

Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures

Animal models for treatment of unresectable liver tumours: a histopathologic and ultra-structural study of cellular toxic changes after electrochemical treatment in rat and dog liver

Serum Thymidine Kinase Activity in Dogs with Malignant Lymphoma: A Potent Marker for Prognosis and Monitoring the Disease

Cellular toxicity induced by different pH levels on the R3230AC rat mammary tumour cell line. An in vitro model for investigation of the tumour destructive properties of electrochemical treatment of tumours

Efficient mapping of mendelian traits in dogs through genome-wide association

Electrochemical treatment (EChT) effects in rat mammary and liver tissue. In vivo optimizing of a dose-planning model for EChT of tumours

Suchergebnisse filtern